Recro Pharma Other Current Assets

Recro Pharma (REPH) currently reports a other current assets of $19M as of December 2023. That compares with $14M in the prior-year period — up 29.2% year over year. Use the charts on this page to explore Recro Pharma's other current assets history and peer comparisons.

Recro Pharma's other current assets increased from $14M to $19M — a 29.2% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Recro Pharma reported $19M in other current assets as of December 2023. That compares with $14M in the prior-year period — up 29.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Recro Pharma, and consider following REPH for alerts when major investors trade the stock.

Recro Pharma is classified in the Healthcare sector. On other current assets, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing REPH with unrelated industries.